semaglutide mash Significantly Improves Steatohepatitis, Fibrosis in Phase III Trial Wegovy becomes first GLP-1RA to

These comparative studies establish the pharmacological basis for the different biological profiles of MT-1 versus MT-II , with MT-1s MC1R preference explaining its predominantly pigmentary and skin photoprotection biology in contrast to MT-IIs broader melanocortin receptor activation producing pro-sexual, pro-erectile, and central appetite effects alongside pigmentation

The positive effects extend to cardiovascular, metabolic, and mental health, which are often overlooked when the focus is solely on the number on the scale or BMI. Other medical conditions that GLP-1 RAs may exacerbate include gastroparesis and diabetic retinopathy, Chadha noted

doi:10.1542/peds.103.3.e26

So, there's a lot of things here that are nuanced and variable in the equation that have nothing to do with the peptide

"Randomized trial of acetylcysteine in idiopathic pulmonary fibrosis." N Engl J Med

They are prepared to meet the specific needs of individual patients when commercially available options are not suitable